F12 PSTVTY

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
F12 PSTVTY
Generic name
ALOE VERA, AVOCADO, BERBERIS AQUIFOLIUM, CALOCHORTUS TOLMIE, CAROBA, CHAMOMILE, CORNSILK, DILL, FAGUS SYLVATICA, GOLD, HYPERICUM PERFORATUM, ILEX AQUIFOLIUM, JUGLANS REGIA, LAVENDER, LYCOPODIUM CLAVATUM, MADIA ELEGANS, MEADIA HENDERSONII, MONARDELLA, MORNING GLORY, NAJA TRIPUDIANS, PENSTEMON DAVIDSONII, PHOSPHORUS, PRUNUS PERSICA, PSORINUM, PULSATILLA VULGARIS, RED CLOVER, ROSA CALIFORNICA, SACRED LOTUS, SARSAPARILLA, SILENE LACINIATA, SILVER, SOLIDAGO CALIFORNICA, SPIDERWORT, WHITE WILLOW
Manufacturer
Apex Energetics Inc.
Product type
HUMAN OTC DRUG
SPL set ID
bca474fe-2bcf-e7d3-e053-2a95a90a49af
SPL ID
0e76cbc6-8d01-7dc8-e063-6294a90a815a
Version
4
Effective date
2024-01-08
Source export date
2026-10-27
Source partition
6
Source file
https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-27/55ffdfed5c29f1b4aed512886bd3fb7831e157cc4948137779971a558752ed2b/drug-label-0006-of-0014.json.zip
Source manifest SHA-256
6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run
20261027T193451Z
Imported at
2026-10-27 20:07:30
Harmonized routes table
Harmonized routes
SUBLINGUAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: If pregnant or breastfeeding , ask a health professional before use. Do not use if clear seal over the cap is broken or missing. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Stop use and ask a doctor if melancholy, despair, abdominal pains, hopelessness, low-spiritedness, fearfulness, or other symptoms do not improve within 7 days or are accompanied by fever.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.